Artiva Biotherapeutics, Inc.ARTVNASDAQ
LOADING
|||
Cash Flow Under Pressure
Below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-55.67M
↓ 43% below average
Average (4y)
$-38.87M
Historical baseline
Range
High:$-13.82M
Low:$-57.13M
CAGR
+41.7%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-55.67M | -9.8% |
| 2023 | $-50.69M | +11.3% |
| 2022 | $-57.13M | -235.5% |
| 2021 | $-17.03M | -23.2% |
| 2020 | $-13.82M | - |